Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Stéphane Doucet, Robert Fowler et al.|The Lancet Respiratory Medicine|2021

Cited by 248